Is insulin resistance the cause of the metabolic syndrome?

References

• Reaven G. M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607
   PubMed Web of Science ®Google Scholar
• DeFronzo R. A., Tobin J., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214–23
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Mari A. How to measure insulin sensitivity. J Hypertens 1998; 16: 895–906
   PubMed Web of Science ®Google Scholar
• DeFronzo R. A., Ferrannini E., Hendler R., Felig P., Wahren J. Regulation of splanchnic and peripheral glucose uptake by insulin and hyperglycemia in man. Diabetes 1983; 32: 35–45
   PubMed Web of Science ®Google Scholar
• Paternostro G., Camici P. G., Lammerstma A. A., Marinho N., Baliga R. R., Kooner J. S., et al. Cardiac and skeletal muscle insulin resistance in patients with coronary artery disease: a study with positron‐emitting tomography. J Clin Invest 1996; 98: 2094–9
   PubMed Web of Science ®Google Scholar
• Golay A., Felber J. P., Jequier E., DeFronzo R. A., Ferrannini E. Metabolic basis of obesity and noninsulin‐dependent diabetes mellitus. Diabetes Metab Rev 1988; 4: 727–47
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Locatelli L., Jequier E., Felber J. P. Differential effects of insulin and hyperglycemia on intracellular glucose disposition in humans. Metabolism 1989; 38: 459–65
   Google Scholar
• Bonadonna R. C., Del Prato S., Saccomani M. P., Bonora E., Gulli G., Ferrannini E., et al. Transmembrane glucose transport in skeletal muscle of patients with non–insulin‐dependent diabetes. J Clin Invest 1993; 92: 486–94
   PubMed Web of Science ®Google Scholar
• Gastaldelli A., Baldi S., Pettiti M., Toschi E., Camastra S., Natali A., et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in hormones. Diabetes 2000; 49: 1367–73
   PubMed Web of Science ®Google Scholar
• Iozzo P., Hallsten K., Oikonen V., Virtanen K. A., Kemppainen J., Solin O., et al. Insulin‐mediated hepatic glucose uptake is impaired in type 2 diabetes: evidence for a relationship with glycemic control. J Clin Endocrinol Metab 2003; 88: 2055–60
   Google Scholar
• Virtanen K. A., Iozzo P., Hallsten K., Huupponen R., Parkkola R., Janatuinen T., et al. Increased fat mass compensates for insulin resistance in abdominal obesity and type 2 diabetes: a positron‐emitting tomography study. Diabetes 2005; 54: 2720–6
   Google Scholar
• Del Prato S., Leonetti F., Simonson D. C., Sheehan P., Matsuda M., DeFronzo R. A. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37: 1025–35
   PubMed Web of Science ®Google Scholar
• Yki‐Järvinen H. Glucose toxicity. Endocr Rev 1992; 13: 415–31
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Gastaldelli A., Miyazaki Y., Matsuda M., Mari A., DeFronzo R. A. beta‐Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005; 90: 493–500
   PubMed Web of Science ®Google Scholar
• Golay A., Swilocky A. L., Chen Y. D., Reaven G. M. Relationship between plasma free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non–insulin‐dependent diabetic individuals. Metabolism 1987; 36: 692–6
   PubMed Web of Science ®Google Scholar
• Randle P. J., Garland P. B., Hales C. N., Newsholme E. A. The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963; i: 785–9
   Google Scholar
• Ferrannini E., Barrett E. J., Bevilacqua S., DeFronzo R. A. Effect of free fatty acids on glucose production and utilization in man. J Clin Invest 1983; 72: 1737–45
   PubMed Web of Science ®Google Scholar
• Groop L. C., Saloranta C., Schenk M., Bonadonna R. C., Ferrannini E., DeFronzo R. A. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non–insulin‐dependent diabetes mellitus. J Clin Endocrinol Metab 1991; 72: 96–107
   PubMed Web of Science ®Google Scholar
• Kelley D. E., Mokan M., Simoneau J. A., Mandarino L. J. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 1993; 92: 9–8
   Google Scholar
• Ferrannini E., Camastra S., Coppack S. W., Fliser D., Golay A., Mitrakou A. Insulin action and nonesterified fatty acids. Proc Nutr Soc 1997; 56: 753–61
   Google Scholar
• Taskinen M. R. Type 2 diabetes as a lipid disorder. Curr Mol Med 2005; 5: 297–308
   PubMed Web of Science ®Google Scholar
• Yki‐Järvinen H. Fat in the liver and insulin resistance. Ann Med 2005; 37: 347–56
   PubMed Web of Science ®Google Scholar
• Greco A. V., Mingrone G., Giancaterini A., Manco M., Morroni M., Cinti S., et al. Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002; 51: 144–51
   PubMed Web of Science ®Google Scholar
• Ginsberg H. N. New perspectives on atherogenesis: role of abnormal triglyceride‐rich lipoprotein metabolism. Circulation 2002; 106: 2137–42
   PubMed Web of Science ®Google Scholar
• Steinberg H. O., Baron A. D. Vascular function, insulin resistance and fatty acids. Diabetologia 2002; 45: 623–34
   PubMed Web of Science ®Google Scholar
• Kashyap S., Belfort R., Gastaldelli A., Pratipanawatr T., Berria R., Pratipanawatr W., et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 2003; 52: 2461–74
   PubMed Web of Science ®Google Scholar
• Camastra S., Bonora E., Del Prato S., Rett K., Weck M., Ferrannini E. Effect of obesity and insulin resistance on resting and glucose‐induced thermogenesis in man. EGIR (European Group for the Study of Insulin Resistance). Int J Obes Relat Metab Disord 1999; 23: 1307–13
   PubMedGoogle Scholar
• Ferrannini E., Buzzigoli G., Bonadonna R., Giorico M. A., Oleggini M., Graziadei L., et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–7
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Natali A., Capaldo B., Lehtovirta M., Jacob S., Yki‐Yarvinen H. Insulin resistance, hyperinsulinemia, and blood pressure. Role of age and obesity. Hypertension 1997; 30: 1144–9
   PubMed Web of Science ®Google Scholar
• Ferrannini E. The phenomenon of insulin resistance: its possible relevance to hypertensive disease. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd Edition, J. H Laragh, B. M Brenner, editors. Raven Press, New York 1995; p 2281–300, In
   Google Scholar
• Yki‐Järvinen H., Utriainen T. Insulin‐induced vasodilatation: physiology or pharmacology?. Diabetologia 1998; 41: 369–79
   PubMed Web of Science ®Google Scholar
• Taddei S., Virdis A., Mattei P., Natali A., Ferrannini E., Salvetti A. Effect of insulin on acetylcholine‐induced vasodilation in normotensive subjects and patients with essential hypertension. Circulation 1995; 92: 2911–8
   PubMed Web of Science ®Google Scholar
• Steinberg H. O., Brechtel G., Johnson A., Fineberg E., Baron A. D. Insulin‐mediated skeletal muscle vasodilatation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172–9
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Taddei S., Santoro D., Natali A., Boni C., Del Chiaro D., et al. Independent stimulation of glucose metabolism and Na/K exchange by insulin in the human forearm. Am J Physiol 1988; 255: E953–8
   Google Scholar
• Montagnani M., Ravichandran L. V., Chen H., Esposito D. L., Quon M. J. Insulin receptor substrate‐1 and phosphoinositide‐dependent kinase‐1 are required for insulin‐stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 2002; 16: 1931–42
   Google Scholar
• Montagnani M., Golovchenko I., Kim I., Koh G. Y., Goalstone M. L., Mundhekar A. N., et al. Inhibition of phosphatidylinositol 3‐kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002; 277: 1794–9
   PubMed Web of Science ®Google Scholar
• Muscelli E., Emdin M., Natali A., Pratali L., Camastra S., Gastaldelli A., et al. Autonomic and hemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998; 83: 2084–90
   Google Scholar
• Ferrannini E., Galvan A. Q., Gastaldelli A., Camastra S., Sironi A. M., Toschi E., et al. Insulin: new roles for an ancient hormone. Eur J Clin Invest 1999; 29: 842–52
   PubMed Web of Science ®Google Scholar
• Porte D., Jr, Baskin D. G., Schwartz M. W. Insulin signaling in the central nervous system: a critical role in metabolic homeostasis and disease from C. elegans to humans. Diabetes 2005; 54: 1264–76
   PubMedGoogle Scholar
• Trovati M., Anfossi G. Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. J Diabetes Complications 2002; 16: 35–40
   PubMed Web of Science ®Google Scholar
• Gastaldelli A., Emdin M., Conforti F., Camastra S., Ferrannini E. Insulin prolongs the QTc interval in humans. Am J Physiol Regul Integr Comp Physiol 2000; 279: R2022–5
   Google Scholar
• Ferrannini E., Natali A., Bell P., Cavallo‐Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 1166–73
   PubMed Web of Science ®Google Scholar
• Gastaldelli A., Sironi A. M., Ciociaro D., Positano V., Buzzigoli E., Giannessi D., et al. Visceral fat and beta cell function in non‐diabetic humans. Diabetologia 2005; 48: 2090–6
   Google Scholar
• Sironi A. M., Gastaldelli A., Mari A., Ciociaro D., Positano V., Buzzigoli E., et al. Visceral fat in hypertension: influence on insulin resistance and beta‐cell function. Hypertension 2004; 44: 127–33
   PubMed Web of Science ®Google Scholar
• Miles J. M., Jensen M. D. Counterpoint: visceral adiposity is not causally related to insulin resistance. Diabetes Care 2005; 28: 2326–8
   Google Scholar
• Dvorak R. V., DeNino W. F., Ades P. A., Poehlman E. T. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal‐weight young women. Diabetes 1999; 48: 2210–4
   PubMed Web of Science ®Google Scholar
• Katzmarzyk P. T., Church T. S., Janssen I., Ross R., Blair S. N. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 2005; 28: 391–7
   PubMed Web of Science ®Google Scholar
• Wisloff U., Najjar S. M., Ellingsen O., Haram P. M., Swoap S., Al‐Share Q., et al. Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 2005; 307: 418–20
   PubMed Web of Science ®Google Scholar
• Ferrannini E., Haffner S. M., Mitchell B. D., Stern M. P. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–22
   PubMed Web of Science ®Google Scholar
• Kahn R., Buse J., Ferrannini E., Stern M. P. The metabolic syndrome: time for a critical appraisal Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2005; 48: 1684–99
   PubMed Web of Science ®Google Scholar